Bacterial Extracellular Vesicles: Potential Therapeutic Applications, Challenges, and Future Prospects

ABSTRACT Almost all cell types naturally secret extracellular vesicles (EVs) in the extracellular space with variable metabolic cargo facilitating intracellular communication, posing immune‐modulation capacity. Thus, “bacterial extracellular vesicles” (BEVs), with their great immunoregulatory, immune response stimulation and disease condition‐altering potential, have gained importance in the medical and therapeutic industry. Various subtypes of BEVs were observed and reported in the literature, such as exosomes (30–150 nm), microvesicles (100–1000 nm), apoptotic bodies (1000–5000 nm), and oncosomes (1000–10,000 nm). As biological systems are complex entities, inserting BEVs requires extra high purity. Various techniques for BEV isolation have been employed alone or with other strategies, such as ultracentrifugation, precipitation, size‐exclusion chromatography, affinity‐based separation, ultrafiltration, and field‐flow fractionation. But to date, no BEV isolation method is considered perfect as the lack of standard protocols limits their scale‐up. Medical research has focused on BEVs to explore their diverse therapeutic potential. This review particularly focused on the recent advancements in the potential medical application of BEVs, current challenges, and prospects associated with their scale‐up.